TargetSomatostatin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories
Curated by PDSP Ki Database
Merck Research Laboratories
Curated by PDSP Ki Database
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.0500nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.0700nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.0900nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.120nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.240nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.240nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.310nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.540nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.590nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.600nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.610nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.620nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.640nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 0.700nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 1.58nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 1.90nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 1.96nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 3.16nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 3.24nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 3.53nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 4.23nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 4.64nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 4.98nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 5.07nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 5.42nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Cricetulus griseus (Chinese hamster))
Novartis
US Patent
Novartis
US Patent
Affinity DataIC50: 6.31nMAssay Description:CFTR activity can be quantified by electrophysiology methods, using the whole-cell configuration of the patch clamp technique (Hamill O, Marty A, Neh...More data for this Ligand-Target Pair